Skip to main content

Published locations for ASPIRE: Carfilzomib-Len-Dex ‘a new standard of care’ for relapsed multiple myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASPIRE: Carfilzomib-Len-Dex ‘a new standard of care’ for relapsed multiple myeloma

User login

  • Reset your password
  • /content/aspire-carfilzomib-len-dex-new-standard-care-relapsed-multiple-myeloma
  • /hematologynews/article/89210/leukemia-myelodysplasia-transplantation/aspire-carfilzomib-len-dex-new
  • /oncologypractice/article/89210/leukemia-myelodysplasia-transplantation/aspire-carfilzomib-len-dex
  • /hematology-oncology/article/89210/leukemia-myelodysplasia-transplantation/aspire-carfilzomib-len-dex